Hot spring biology: plans to buy back shares worth 100 million to 200 million yuan for employee holding or incentives.

Hot Rock Bio announced that the company held a board meeting on November 11 to approve a share repurchase program through centralized competitive bidding trading. The repurchase fund is 100 million to 200 million yuan, sourced from the company's funds, with a price not exceeding 244 yuan per share, intending to repurchase 409,837 to 819,672 shares, accounting for 0.44% to 0.88% of the total share capital, for use in employee stock ownership plans or stock incentives. The repurchase period is within 12 months from the approval of the board. In addition, the controlling shareholders and other related parties have reduced their holdings in the six months prior to the resolution, and there is no specific plan to increase or decrease holdings during the repurchase period. This repurchase program involves risks such as price, funds, and significant events.